Drugs / MK3134
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01110616 | Jun → Oct 2010 | dementia | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 1 | NCT00887601 | Aug 2007 → May 2008 | dementia | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 1 | NCT01181310 | Jun → Oct 2007 | dementia | Merck Sharp & Dohme LLC | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK3134 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00887601 ↗ |
| Route | Oral | “orally” NCT01110616 ↗ |